Difference between revisions of "Nio K, et al. J. Hepatol. (2015) cited as Ref 711 in DOI: 10.1038/s41392-020-0110-5 (Q9974)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1016/j.jhep.2015.06.009, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: Page(s) (P105): 1164-1172, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (5 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 26095183 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2015
| ||||||||||||||
| Property / Publication Date: 2015 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | J. Hepatol. | ||||||||||||||
| Property / Published In Name String: J. Hepatol. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 63 | ||||||||||||||
| Property / Volume: 63 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma (English) | ||||||||||||||
| Property / title: Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 1164-1172 | ||||||||||||||
| Property / Page(s): 1164-1172 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:50, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Nio K, et al. J. Hepatol. (2015) cited as Ref 711 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Nio K
0 references
2015
0 references
J. Hepatol.
0 references
63
0 references
Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma (English)
0 references
1164-1172
0 references
